Aktuella utlysningar, vecka 46, 2024
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska anslag
Forskarnätverk 2024 – Östersjöstiftelsen
Med stödformen forskarnätverk avses stöd till att antingen skapa eller upprätthålla redan etablerade nätverk mellan forskare. Nätverken ska vara forskningsinitierande och syfta till att bidra till kommande forskning genom vetenskapliga möten och kontakter där forskare kan definiera, avgränsa och formulera forskningsidéer som i förlängningen kan leda fram till ansökningar om forskningsmedel. Kan sökas av: Grupp av forskare. Projektledare ska vara forskare från lärosäte i Sverige. Nätverket ska inkludera forskare vid Södertörns högskola. Det är önskvärt att en övervägande del av deltagarna i nätverkets kärngrupp kommer från forskningsmiljöer utanför Sverige. Kan inkludera doktorander. Projektperiod: Maximalt ett år.
Closing date: Utlysning och anvisningar för 2025 publiceras 16 december 2024.
Stipendier - Svensk Förening för Sömnforskning och Sömnmedicin (SFSS)
SFSS utlyser forsknings- och resestipendier för föreningens medlemmar. Forskningsstipendier kan sökas för kostnader i samband med forskningsprojekt och resestipendier kan sökas för kostnader (resa, logi, kongressavgift) i samband med kongressdeltagande, kurs eller studiebesök i forskargrupp eller motsvarande. Forskningsprojektet eller aktivitet som resestipendiet avser ska ha inriktning mot grundforskning, samhällsvetenskaplig forskning eller klinisk forskning inom sömn och dygnsrytm. Resestipendier är SEK 5,000 kr för resor inom Europa och SEK 10,000 kr för resor utanför Europa.
Closing date: December 30, 2024
Research grants – LEO Foundation
Supports the best dermatology research projects worldwide. The foundation welcomes applications for research projects that improve the understanding of skin biology as well as the underlying medicinal, biological, chemical, or pharmacological mechanisms of dermatological diseases and their symptoms. It also welcomes applications for projects that address clinical issues among people who are at risk of developing, or have developed, a skin disease, including how it impacts their quality of life and the societal costs involved.
The typical amount approved for funding of a research grant is DKK 2-4 million for a period of 1-3 years. The following types of expenses are covered: Salary and mandatory benefits for employees including main applicant; Running costs / operating expenses incl bench fees; Equipment; Publication costs; Travel and conference expenses; Tuition fees for PhD students; Administrative costs up to 5%.
Closing date: January 8, 2025
Resestipendier – Vårdprofessioner inom Cardiologi (VIC)
Stipendier stöder medlemmars deltagande i utbildningsdagar, konferenser, kongresser och studiebesök, nationellt som internationellt, inom hjärtsjukvård. Då digitala events har blivit allt vanligare efter Covid 19-pandemin kan man i nuläget även ansöka om resestipendium för digitala utbildningar, kongresser och events.
Closing date: January 31, 2025
Emerging investigator grants for research within industrial biotechnology and environmental biotechnology - Nordic region - Novo Nordisk Foundation
The intention of the grant is to enable excellent scientists to establish their own research group or to further strengthen their recently started group. The proposed research should address major challenges within industrial biotechnology or environmental biotechnology. The research should be fundamental in character but have a strategic outlook to scaling potential(s), contribute to sustainability and, if relevant, increase productivity.
The proposed research must involve a clear element of biotechnology. The research projects should preferably include one or more of the following topics: (1) Use or engineering of biological/biotechnological tools, systems or microorganisms for synthesis and production of valuable products (e.g. energy, fuels, chemicals, proteins, and materials); (2) Development of technologies and processes for bioproduction; (3) Improvement of the efficiency and/or sustainability of biomanufacturing; (4) Use or engineering of biological/biotechnological tools, systems, or microorganisms to protect or improve the environment; (5) Understanding, protection, or manipulation of natural or industrial ecosystems in relation to application of biotechnology; (6) Data science to advance research within industrial or environmental biotechnology, including related ecosystems research.
Closing date: January 10, 2025
Ascending investigator grants for research within industrial biotechnology and environmental biotechnology - Nordic region - Novo Nordisk Foundation
The ascending investigator grant supports the continued development and consolidation of excellent research leaders within industrial biotechnology and environmental biotechnology in the Nordic countries. The proposed research should address major challenges within industrial biotechnology or environmental biotechnology. The research should be fundamental in character but have a strategic outlook to scaling potential(s), contribute to sustainability and, if relevant, increase productivity.
Research projects should address one of more of the following topics: (1) use or engineering of biological or biotechnological tools, systems or microorganisms for synthesis and production of valuable products (e.g. energy, fuels, chemicals, proteins, and materials); (2) development of technologies and processes for bioproduction; (3) improvement of the efficiency and/or sustainability of biomanufacturing; (4) use or engineering of biological or biotechnological tools, systems or microorganisms to protect or improve the environment; (5) understanding, protection or manipulation of natural or industrial ecosystems in relation to application of biotechnology; (6) data science to advance research within industrial or environmental biotechnology, including related ecosystems research.
Closing date: January 10, 2025
Forskningsanslag - Stiftelsen Clas Groschinskys Minnesfond
Forskningsanslag kommer år 2024 att ges för forskning inom områden: (1) Infektioner; (2) Immunterapi mot cancer; (3) Autoimmuna endokrina sjukdomar; (4) Immunologiska reaktioner associerade med psykiatrisk sjukdom. Inom dessa områden riktas stödet till forskare, som efter disputation och postdoktoral eller klinisk vidareutbildning, är i färd med att bygga upp ett eget projekt och forskargrupp.
Forskningsanslagen uppgår till högst 300.000 kronor per anslag. Som regel beviljas anslag för högst två år, men ett år i taget. Undantag kan dock göras för högprioriterade projekt eller när andra särskilda omständigheter föreligger.
Obs! Ansökningsperioden öppnas den 1 december 2024. Blanketter och anvisningar kommer att finnas från den 15 november 2024.
Closing date: January 31, 2025
Bengt Ihre Research Fellowship - Bengt Ihres Forskningsfond
Ger stöd till läkare och klinisk forskare efter disputation att med handlednings- och forskningsresurser kunna utföra kliniska på sin hemklinik i samarbete med de inom Fellowship programmet relaterade universiteten och etablerade nätverk. Programmet individualiseras efter sökande och kan komma att inkludera del av lön samt finansiera de till projektet knutna kostnaderna såsom statistikkonsulttjänster, etiktillstånd, laborativa resurser och analyser, forskningssköterskor med mera som krävs på plats. Fellowship-programmet löper under två år och ska vara förenat med klinisk tjänstgöring. Kan sökas av disputerad läkare med minst påbörjad specialist-tjänstgöring inom gastroenterologisk eller gastrokirurgisk specialitet. Endast medlemmar i Svenska Läkaresällskapet är behöriga att söka.
Closing date: February 1, 2025
Instrument-, teknik- och metodutveckling - Stiftelsen för Strategisk Forskning (SSF)
Projekten ska möjliggöra vetenskapliga eller tekniska genombrott genom att utveckla nya instrument- och/eller metodutveckling och/eller tekniker, inriktade på viktiga tillämpningsproblem. Projekten ska möjliggöra framtida forskning, innovationer eller tjänster kring vilka industri och/eller offentlig sektor kan växa. Bidragen kan sökas av forskningsingenjörer, icke-fakultetsforskare, forskare, doktorer och postdoktorer för utveckling av nya verktyg och metoder, samtidigt som det ska främja bidragstagarnas egna karriärvägar. Varje projekt kan söka sex till tio miljoner kronor, som kommer att betalas ut under en treårsperiod.
Closing date: March 25, 2025
Europeiska anslag
EFSD/Lilly young investigator research awards
The European Foundation for the Study of Diabetes and Lilly invite applications for their young investigator research awards. These encourage innovative research in the field of diabetes and its complications, and promote excellence in medical education.
Eligibility: Scientists and clinicians at an early stage of their career, up to 7 years since completion of their most recent degree (PhD, MSc, or MD degrees) are eligible. Eligibility can be extended for reasons such as maternity, paternity, illness, national service, clinical training, natural disasters, or asylum, if clearly described. The time since the last degree may not exceed seven years before 1 January 2024. Fellows may not hold a permanent appointment. Applicants to all EFSD programmes are encouraged to become paid-up members of EASD. Awards must be held at a non-profit institution based in Europe or an associated country.
Awards are worth €50,000 each. 10% INDI coverage
Deadline: 17 February 2025
Medical research call for proposals in neuromuscular disorders - French Muscular Dystrophy Association
The French Muscular Dystrophy Association invites applications for its medical research call for proposals in neuromuscular disorders. This supports medical research projects that aim to improve the care and management of patients, the knowledge or neuromuscular disorders and their progression, as well as the quality of life of patients affected by neuromuscular disorders. Projects may focus on the following research topics:
- natural history of disease and/or epidemiological studies;
- patients' management or healthcare;
- neonatal screening projects;
- assessment of new outcome measures;
- e-health and artificial intelligence.
There is a particular focus on biomarkers and outcome measures to more efficiently assess neuromuscular disease drugs or medical devices.
Budget: 40,000€ to 100,000€ per year, max. 2 years. No INDI coverage
Eligibility: Research grants are open to researchers or clinical investigators holding a permanent position or equivalent, in an academic, governmental or private institution. Proposals from groups outside France are strongly encouraged to include a French component.
Deadline: 21 January 2025
HORIZON-EIC-2025-PATHFINDERCHALLENGES-01 - EIC pathfinder challenges - European Commission (EC)
Horizon Europe: Innovative Europe, under the European Innovation Council, invites applications for its pathfinder challenges call. This supports new, cutting-edge directions in science and technology to disrupt a field and a market or create new opportunities by realising innovative technological solutions to selected challenges.
- Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer: to create interactive GenAI autonomous agents and/or a combination of them that provide clinicians with a holistic end to end perspective of patient care;
Eligibility: The EIC Pathfinder Challenges support collaborative or individual research and innovation from consortia or from single legal entities established in a Member State or an Associated Country. Consortia of two entities must be comprised of independent legal entities from two different Member States or Associated Countries. Consortia of three or more entities must include as beneficiaries at least three legal entities, independent from each other and each established in a different country as follows:
- at least one legal entity established in a Member State;
- at least two other independent legal entities, each established in different Member States or Associated Countries.
The legal entities may for example be universities, research organisations, SMEs, start-ups, natural persons. In the case of single beneficiary projects, mid-caps and larger companies will not be permitted.
Deadline: 29 October 2025
Amerikanska anslag
Federal Funding
Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
Funding Opportunity ID: PAR-25-201
Upcoming deadline: standard due dates until October 5th 2027.
Abstract: This notice of funding opportunity (NOFO) seeks implementation research projects focused on the integrating mental health services with chronic health care (for both communicable and non-communicable conditions) across various healthcare and non-healthcare settings (such as schools, places of worship, and community centers) in low and middle-income countries (LMICs). The objective is to develop, refine, and evaluate innovative strategies to facilitate the integration of mental health care with other services. This NOFO aims to support research geared towards implementing, scaling up, and ensuring the financial sustainability of integrated mental health care models, with the overarching goal of enhancing the availability, accessibility, utilization, and quality of mental health care services in both healthcare and non-healthcare settings. In addition, this NOFO seeks to strengthen sustainable mental health research capacity in LMICs.
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01, R21 Clinical Trial Not Allowed)
Funding Opportunity ID: PAR-25-107 (R01); PAR-25-108 (R21)
Upcoming deadline: February 05, 2025
Abstract: Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactions between microorganisms, tumors, and the immune system, and to explore their clinical potential for cancer imaging, therapeutics or diagnostics. Projects can focus on using microorganisms as anti-tumor agents, as activators of anti-tumor immunity, or as delivery vehicles for treatment, diagnosis, or imaging, complementing or synergizing with existing tools and approaches. This NOFO will support basic mechanistic and preclinical studies in cell culture and animal models. Applicants are encouraged to address both the microbial and tumor aspects of microbial tumor interactions relevant to microbial-based cancer therapy (including therapies for oral cancer), tumor imaging, tumor detection, or diagnosis.
Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)
Funding Opportunity ID: RFA-DA-26-024
Upcoming deadlines February 27, 2025
Abstract: This notice of funding opportunity (NOFO) addresses a crucial research gap regarding approaches to understanding and enhancing relationships individuals with a substance use disorder (SUD) have with their loved ones. Family, loved ones, and support persons play a critical role in the recovery process and are a critical element of the recovery capital of an individual with a SUD. This NOFO seeks phased (R61/R33) studies that address the role of support persons and loved ones in six focal areas: (1) developing interventions to enhance the well-being and coping skills among support persons; (2) enhancing knowledge of effective interventions for SUDs and reducing stigma, negative attitudes, and misconceptions among support persons; (3) testing enhancements to existing evidence-based interventions and practices to include engagement of support persons; (4) developing new interventions or adapting existing interventions to leverage support persons as lay interventionists; (5) developing and testing care navigation interventions and resources, particularly during care transitions; and (6) dyadic approaches to support engagement in evidence-based care when both parties have experienced or are experiencing a SUD.
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Funding Opportunity ID: PA-25-172
Upcoming deadlines standard due dates until October 5th, 2027
Abstract: This notice of funding opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, digital health and data science, and implementation science.
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Funding Opportunity ID: PA-25-253
Upcoming deadlines standard due dates until June 16th, 2028
Abstract: Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (e.g. epidemiologic, biomedical, behavioral, health care delivery or clinical).
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: PAR-24-306
Upcoming deadlines standard due dates until June 5th, 2026
Abstract: Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research.
The NCI, through this NOFO, encourages submission of projects devoted to demonstrating that mammalian models, including organoids, tumoroids and cell models, used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patient benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that use mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this NOFO could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally.
Foundation
Ann Theodore Foundation (US) – Request for Proposal Breakthrough Sarcoidosis Initiative
Upcoming deadlines: Full application – 20th January, 2025
Amount: Projects led by individual researchers will be eligible for up to US$200,000 in funding for direct costs per year plus 15 percent in indirect costs, totaling US$230,000 per year, and US$460,000 over two years. Interdisciplinary teams will be eligible for up to US$250,000 in funding for direct costs per year plus 15 percent in indirect costs, totaling US$287,000 per year for a total of $575,000 over two years.
Eligibility: Open to all (MD/PhD).
Abstract: We are open to proposals investigating sarcoidosis in any organ system, but studies examining organ systems outside of the lungs and heart will be prioritized. The scientific focus of sarcoidosis proposals shall address one or more of the following focus areas:
- Studies that seek to understand the underlying causes of clinical heterogeneity in sarcoidosis, employing approaches inclusive of genetics, molecular biology, and epidemiological studies
- Studies that examine the heterogeneity of responses to therapeutics
- Research projects that examine the genetic, social, and/or environmental determinants of sarcoidosis development, progression, and persistence
- Studies on other potential causes of sarcoidosis, including autoimmune and/or infectious risks for sarcoidosis
- Studies that seek to understand the biology of granuloma formation, propagation, and persistence in sarcoidosis
- Investigations into the immunobiology of sarcoidosis, such as immunotyping and immunodissections
- Studies that elucidate the mechanisms of downstream effects and comorbidities in sarcoidosis (e.g., fibrosis)
- Studies that involve the application of new tools or technologies that will improve the understanding of the basic biology of sarcoidosis
- Ancillary studies that examine the cellular and molecular biological effects of off-label therapeutics
Development or improvement of a computational, cellular, or animal model for further investigation of sarcoidosis
Simons Foundation (US) – Fellows-to-Faculty Award
Upcoming deadlines: January 14, 2025
Amount: Each fellow is provided up to five (5) years of financial support, split into a faculty research award over three (3) years and an optional postdoctoral award for a maximum of two (2) years.
The Faculty Research Award includes:
- Total budget of $600,000 USD, inclusive of 20 percent indirect costs.
- $85,000 USD stipend
- $10,000 USD career development allowance
- $15,000 USD health insurance and other benefits allowance
The Postdoctoral Award includes the following, annually:
Eligibility: The program is for individuals whose backgrounds and experiences are underrepresented in science, such as members of historically underrepresented racial or ethnic groups, individuals whose gender, gender identity, sexual orientation and/or disability status is underrepresented in science, or other individuals with disadvantaged social and/or economic backgrounds. For additional information, see our FAQ
Abstract: For the 2025 request for applications (RFA), we seek to support scientists whose scientific vision for their future independent laboratory contributes to the mission of either or both of the following scientific areas:
- Simons Foundation Autism Research Initiative (SFARI), consistent with SFARI scientific perspectives
- Simons Collaboration on Plasticity and the Aging Brain (SCPAB), consistent with the SCPAB’s mission
US Embassy Stockholm, (US) – Small Grants
Upcoming deadlines: Applications for this Notice of Funding Opportunity will be reviewed on a rolling-basis with the following schedule:
- November 2024: results to be advised the last week of January 2025 (estimated);
- March 2025: results to be advised last week of April 2025 (estimated);
- May 2025: results to be advised last week of June 2025 (estimated)
- July 2025: results to be advised last week of August 2025 (estimated)
Amount: awards may range from a minimum of $500 to a maximum of $100,000 (approximately) .
Eligibility: Applicants must be not-for-profit organizations/associations or individuals, including think tanks and civil society/non-governmental organizations; educational institutions; individuals; and foreign public entities.
Abstract: All programs must include a link to the United States and/or an element that builds understanding of the United States including, but not limited to U.S. policy, people, culture and/or perspectives. Programs must be focused on Swedish or regional audiences/participants.
Examples of PDS Grants Program projects include, but are not limited to:
– Academic and professional lectures, seminars, and speaker programs;
– Skill building training programs;
– Artistic and cultural workshops, joint performances, and exhibitions; or
– Professional and academic exchanges and projects.
The Embassy encourages the submission of unique and creative proposals from a wide variety of sources.
International Society for the Study of the Lumbar Spine (US) - Basic Science Research Grant
Upcoming deadlines: Full application – 31st January, 2025
Amount: The winning proposal will receive a US$20,000 award.
Eligibility: At least one investigator must be a current ISSLS member. The principal investigator must be 45 years of age or younger.
Abstract: This grant sponsors a research proposal in the field of basic science (including biomechanical science).